|Datasheet||Specific References||Reviews||Related Products||Protocols|
|ORF Clone of Homo sapiens EPH receptor B4 DNA.|
|HTK, MYK1, TYRO11|
|pMD18-T Simple Vector|
|Identical with the Gene Bank Ref. ID sequence except for the point mutation 1314 T/C，1752 A/G，1890 C/T, 2934 T/C not causing the amino acid variation.|
|Whatman FTA elute card (Cat: WB120410) contains 5-10 μg of plasmid.|
|The Whatman FTA elute card can be stored at room temperature for three months under dry condition.|
pMD18-T Simple Vector is a high-efficiency TA cloning vector constructed from pUC18, of which the initial multiple cloning sites (MCS) were destroyed. Thus the cDNA should be amplified by PCR with primers containing a restriction site for subclone. Competent cells appropriate for pUC18 are also appropriated for the Vector, e.g. JM109, DH5α, TOP10. The pMD18-T Simple Vector is 2.6kb in size. Selection of the plasmid in E. coli is conferred by the ampicillin resistance gene. The coding sequence was inserted by TA cloning at site 425.
The coding sequence can be amplified by PCR with M13-47 and RV-M primers.
|Human EphB4 Gene cDNA Clone (full-length ORF Clone), expression ready, His-tagged||HG10235-M-H|
|Human EphB4 Gene cDNA Clone (full-length ORF Clone), expression ready, Myc-tagged||HG10235-M-M|
|Human EphB4 Gene cDNA Clone (full-length ORF Clone), expression ready, untagged||HG10235-M-N|
|Human EphB4 Gene cDNA Clone (full-length ORF Clone), expression ready, HA-tagged||HG10235-M-Y|
|Product name||Product name|
Ephrin type-B receptor 4 is a protein that in humans is encoded by the EPHB4 gene. It is a single-pass type I membrane protein belonging to the ephrin receptor subfamily of protein kinase superfamily. Members of the ephrin and Eph family are local mediators of cell function through largely contact-dependent processes in development and in maturity. Furthermore, EphB4 protein and the corresponding ligand Ephrin-B2 contribute to tumor growth in various human tumors. EphB4 protein has tumor suppressor activities and that regulation of cell proliferation, extracellular matrix remodeling, and invasive potential are important mechanisms of tumor suppression. Therefore, Ephrin-B2/EphB4 may be recognized as a novel prognostic indicator for cancers.